June 2020
Volume 61, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2020
Peripheral blood transcriptome in ocular sarcoidosis
Author Affiliations & Notes
  • John Alexander Gonzales
    F.I. Proctor Foundation, F.I. Proctor Foundation, San Francisco, California, United States
    Ophthalmology, University of California, San Francisco, California, United States
  • Jaskirat Takhar
    F.I. Proctor Foundation, F.I. Proctor Foundation, San Francisco, California, United States
    University of Hawaii, Hawaii, United States
  • Ashlin Joye
    F.I. Proctor Foundation, F.I. Proctor Foundation, San Francisco, California, United States
  • Nisha Acharya
    F.I. Proctor Foundation, F.I. Proctor Foundation, San Francisco, California, United States
    Ophthalmology, University of California, San Francisco, California, United States
  • Thuy Doan
    F.I. Proctor Foundation, F.I. Proctor Foundation, San Francisco, California, United States
    Ophthalmology, University of California, San Francisco, California, United States
  • Footnotes
    Commercial Relationships   John Gonzales, None; Jaskirat Takhar, None; Ashlin Joye, None; Nisha Acharya, None; Thuy Doan, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4295. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Alexander Gonzales, Jaskirat Takhar, Ashlin Joye, Nisha Acharya, Thuy Doan; Peripheral blood transcriptome in ocular sarcoidosis. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4295.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify distinct peripheral blood transcriptomes that differentiates participants with sarcoidosis-associated uveitis from those with Vogt-Koyanagi-Harada (VKH)-associated uveitis and healthy controls.

Methods : Cross-sectional study of participants enrolled into the Biomarkers in Ocular Sarcoidosis Study at the Proctor Foundation, University of California, San Francisco.

Ten participants with sarcoidosis-associated uveitis (8 with pulmonary sarcoidosis, 1 with central nervous system sarcoidosis, and 1 with conjunctival sarcoidosis), 9 participants with VKH-associated uveitis, and 8 healthy controls were enrolled into BOSS. Participants had a baseline ocular examination and provided a peripheral blood sample collected into PAXgene RNA tubes (BD Biosciences, San Jose, CA) and stored at -80 degrees Celsius. All samples were simultaneously prepared for metagenomic RNA sequencing with RNA extracted from peripheral blood. Analysis of sequenced data used an in-house rapid computational pipeline to classify host genes. Quality filtered RNA transcripts were aligned to ENSEMBL CRCh38 human genome build using STAR2. Genes were filtered to include only protein-coding genes that were expressed in at least 25% of participants and analyzed with DESeq2.

Results : Thirty-eight transcripts were identified to be differentially expressed based on FDR <0.01 in participants with ocular sarcoidosis compared to healthy controls. These transcripts included toll-like receptor 2, MAX interactor 1, and galectin 3, which are involved in regulating innate immunity, regulation of T-cells, cell adhesion, apoptosis, or tumor suppression. Additionally, there was no overlap in the genes that were differentially expressed between the three comparison groups: sarcoidosis-control, sarcoidosis-VKH, and VKH-control, indicating distinct transcriptome profiles between disease types.

Conclusions : This study suggests that the whole peripheral blood transcriptional profile in ocular sarcoidosis may allow such patients to be distinguished from healthy controls. This peripheral blood transcriptional signature reflects important inflammatory pathways and suggests candidate genes may be further explored.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×